Your browser doesn't support javascript.
loading
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control.
Glynne-Jones, R; Counsell, N; Quirke, P; Mortensen, N; Maraveyas, A; Meadows, H M; Ledermann, J; Sebag-Montefiore, D.
Afiliação
  • Glynne-Jones R; Department of Medical Oncology, Mount Vernon Centre for Cancer Treatment, London. Electronic address: rob.glynnejones@nhs.net.
  • Counsell N; CRUK & UCL Cancer Trials Centre, London.
  • Quirke P; Leeds Institute of Molecular Medicine, University of Leeds, Leeds.
  • Mortensen N; Department of Colorectal Surgery, University of Oxford, Oxford.
  • Maraveyas A; Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, UK.
  • Meadows HM; CRUK & UCL Cancer Trials Centre, London.
  • Ledermann J; CRUK & UCL Cancer Trials Centre, London.
  • Sebag-Montefiore D; Leeds Institute of Molecular Medicine, University of Leeds, Leeds.
Ann Oncol ; 25(7): 1356-1362, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24718885

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article